CAJ | 학술논문

30％～50％的非小细胞肺癌（NSCLC）患者在疾病进展过程中发生脑转移。NSCLC 脑转移是目前肿瘤治疗的难点之一，治疗措施有手术、放疗、化疗、生物靶向治疗等。目前推荐采用新的预后评分系统来预判患者的预后，根据预后评分选择个体化的治疗方法。
30％～50％적비소세포폐암（NSCLC）환자재질병진전과정중발생뇌전이。NSCLC 뇌전이시목전종류치료적난점지일，치료조시유수술、방료、화료、생물파향치료등。목전추천채용신적예후평분계통래예판환자적예후，근거예후평분선택개체화적치료방법。
30%-50% patients with non-small cell lung cancer (NSCLC)will occur cerebral metastasis in the course of their illnesses.NSCLC with brain metastases is one of the difficulties in cancer treatment. Treatment measures include surgery,radiotherapy,chemotherapy,biological targeted therapy and so on.The new prognostic scoring system is recommended to predict the prognosis of patients.Individualized treatment methods should be chosen according to prognostic score.